Related references
Note: Only part of the references are listed.Short A beta peptides attenuate A beta 42 toxicity in vivo
Brenda D. Moore et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Common proteomic profiles of induced pluripotent stem cell-derived three-dimensional neurons and brain tissue from Alzheimer patients
Mei Chen et al.
JOURNAL OF PROTEOMICS (2018)
Analysis of 138 pathogenic mutations in presenilin-1 on the in vitro production of Aβ42 and Aβ40 peptides by γ-secretase
Linfeng Sun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation
Anna Ochalek et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
Stem cell models of Alzheimer's disease: progress and challenges
Charles Arber et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
The Alzheimer's Disease γ-Secretase Generates Higher 42:40 Ratios for β-Amyloid Than for p3 Peptides
Gabriele Siegel et al.
CELL REPORTS (2017)
Taming Human Genetic Variability: Transcriptomic Meta-Analysis Guides the Experimental Design and Interpretation of iPSC-Based Disease Modeling
Pierre-Luc Germain et al.
STEM CELL REPORTS (2017)
Alzheimer's-Causing Mutations Shift Aβ Length by Destabilizing γ-Secretase-Aβn Interactions
Maria Szaruga et al.
CELL (2017)
The genetic landscape of Alzheimer disease: clinical implications and perspectives
Caroline Van Cauwenberghe et al.
GENETICS IN MEDICINE (2016)
Transmembrane Substrate Determinants for γ-Secretase Processing of APP CTFβ
Marty A. Fernandez et al.
BIOCHEMISTRY (2016)
The amyloid hypothesis of Alzheimer's disease at 25years
Dennis J. Selkoe et al.
EMBO MOLECULAR MEDICINE (2016)
Clinical phenotype and genetic associations in autosomal dominant familial Alzheimer's disease: a case series
Natalie S. Ryan et al.
LANCET NEUROLOGY (2016)
The dynamic mechanism of presenilin-1 function: Sensitive gate dynamics and loop unplugging control protein access
Arun Kumar Somavarapu et al.
NEUROBIOLOGY OF DISEASE (2016)
Familial Alzheimer's Disease Mutations in Presenilin Generate Amyloidogenic Ab Peptide Seeds
Sarah Veugelen et al.
NEURON (2016)
CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease
Shorena Janelidze et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
Self-Organizing 3D Human Neural Tissue Derived from Induced Pluripotent Stem Cells Recapitulate Alzheimer's Disease Phenotypes
Waseem K. Raja et al.
PLOS ONE (2016)
Amyloid precursor protein expression and processing are differentially regulated during cortical neuron differentiation
Petra Bergstrom et al.
SCIENTIFIC REPORTS (2016)
Qualitative changes in human γ-secretase underlie familial Alzheimer's disease
Maria Szaruga et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Impact of cerebrospinal fluid matrix or the detection of Alzheimer's disease with Aβ42 and influence of disease on the total-Aβ42/Aβ40 ratio.
J. Randall Slemmon et al.
JOURNAL OF NEUROCHEMISTRY (2015)
Cooperative Roles of Hydrophilic Loop 1 and the C-Terminus of Presenilin 1 in the Substrate-Gating Mechanism of γ-Secretase
Shizuka Takagi-Niidome et al.
JOURNAL OF NEUROSCIENCE (2015)
APP Metabolism Regulates Tau Proteostasis in Human Cerebral Cortex Neurons
Steven Moore et al.
CELL REPORTS (2015)
Cerebrospinal Fluid Aβ40 Improves the Interpretation of Aβ42 Concentration for Diagnosing Alzheimer’s Disease
Aline Dorey et al.
Frontiers in Neurology (2015)
The familial Alzheimer's disease APPV717I mutation alters APP processing and Tau expression in iPSC-derived neurons
Christina R. Muratore et al.
HUMAN MOLECULAR GENETICS (2014)
γ Secretase Associated with Lipid Rafts
Nobutaka Matsumura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Alzheimer Presenilin-1 Mutations Dramatically Reduce Trimming of Long Amyloid β-Peptides (Aβ) by γ-Secretase to Increase 42-to-40-Residue Aβ
Marty A. Fernandez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Generation of cerebral organoids from human pluripotent stem cells
Madeline A. Lancaster et al.
NATURE PROTOCOLS (2014)
Characterization and Molecular Profiling of PSEN1 Familial Alzheimer's Disease iPSC-Derived Neural Progenitors
Andrew A. Sproul et al.
PLOS ONE (2014)
Induced Pluripotent Stem Cells from Familial Alzheimer's Disease Patients Differentiate into Mature Neurons with Amyloidogenic Properties
Vasiliki Mahairaki et al.
STEM CELLS AND DEVELOPMENT (2014)
Amyloid-beta 42 adsorption following serial tube transfer
Jamie Toombs et al.
ALZHEIMERS RESEARCH & THERAPY (2014)
Changed membrane integration and catalytic site conformation are two mechanisms behind the increased Aβ42/Aβ40 ratio by presenilin 1 familial Alzheimer-linked mutations
Johanna Wanngren et al.
FEBS OPEN BIO (2014)
The Presenilin-1 ΔE9 Mutation Results in Reduced γ-Secretase Activity, but Not Total Loss of PS1 Function, in Isogenic Human Stem Cells
Grace Woodruff et al.
CELL REPORTS (2013)
Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative
Hugo Vanderstichele et al.
ALZHEIMERS & DEMENTIA (2012)
The mechanism of γ-Secretase dysfunction in familial Alzheimer disease
Lucia Chavez-Gutierrez et al.
EMBO JOURNAL (2012)
Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells
Mason A. Israel et al.
NATURE (2012)
Directed differentiation of human pluripotent stem cells to cerebral cortex neurons and neural networks
Yichen Shi et al.
NATURE PROTOCOLS (2012)
Creation of an Open-Access, Mutation-Defined Fibroblast Resource for Neurological Disease Research
Selina Wray et al.
PLOS ONE (2012)
Fluid Biomarkers in Alzheimer Disease
Kaj Blennow et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Amyloid Precursor Protein Processing and Alzheimer's Disease
Richard J. O'Brien et al.
ANNUAL REVIEW OF NEUROSCIENCE, VOL 34 (2011)
The Japanese Mutant Aβ (ΔE22-Aβ1-39) Forms Fibrils Instantaneously, with Low-Thioflavin T Fluorescence: Seeding of Wild-Type Aβ1-40 into Atypical Fibrils by ΔE22-Aβ1-39
Adam L. Cloe et al.
BIOCHEMISTRY (2011)
Modeling familial Alzheimer's disease with induced pluripotent stem cells
Takuya Yagi et al.
HUMAN MOLECULAR GENETICS (2011)
A more efficient method to generate integration-free human iPS cells
Keisuke Okita et al.
NATURE METHODS (2011)
Potent amyloidogenicity and pathogenicity of Aβ43
Takashi Saito et al.
NATURE NEUROSCIENCE (2011)
A novel pathway for amyloid precursor protein processing
Erik Portelius et al.
NEUROBIOLOGY OF AGING (2011)
γ-Secretase: Successive Tripeptide and Tetrapeptide Release from the Transmembrane Domain of β-Carboxyl Terminal Fragment
Mako Takami et al.
JOURNAL OF NEUROSCIENCE (2009)
The Alzheimer β-amyloid (Aβ1-39) dimer in an implicit solvent
Priya Anand et al.
JOURNAL OF CHEMICAL PHYSICS (2008)
Characterization of amyloid ß peptides in cerebrospinal fluid by an automated immunoprecipitation procedure followed by mass spectrometry
Erik Portelius et al.
JOURNAL OF PROTEOME RESEARCH (2007)
β-secretase cleavage at amino acid residue 34 in the amyloid β peptide is dependent upon γ-secretase activity
XP Shi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The transmembrane domain of the Alzheimer's β-secretase (BACE1) determines its late Golgi localization and access to β-amyloid precursor protein (APP) substrate
RQ Yan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Degradation of the Alzheimer's amyloid β peptide by endothelin-converting enzyme
EA Eckman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Brain expression of presenilins in sporadic and early-onset, familial Alzheimer's disease
PM Mathews et al.
MOLECULAR MEDICINE (2000)
Share Paper
